Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Apollo Endosurgery Inc    LPTN

APOLLO ENDOSURGERY INC (LPTN)
My previous session
Most popular
  Report  
Delayed Quote. Delayed  - 01/18 03:59:33 pm
3.38 USD   +4.00%
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/14/2019 01/15/2019 01/16/2019 01/17/2019 01/18/2019 Date
3.07(c) 3.09(c) 3.25(c) 3.25(c) 3.38(c) Last
48 939 11 680 74 121 7 821 14 943 Volume
-1.60% +0.65% +5.18% 0.00% +4.00% Change
More quotes
Financials (USD)
Sales 2018 60,6 M
EBIT 2018 -30,7 M
Net income 2018 -35,9 M
Debt 2018 -
Yield 2018 -
Sales 2019 56,7 M
EBIT 2019 -33,9 M
Net income 2019 -37,4 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 1,22x
Capi. / Sales2019 1,31x
Capitalization 74,0 M
More Financials
Company
Apollo Endosurgery, Inc., formerly Lpath, Inc., is a medical device company. The Company is focused on less invasive therapies for the treatment of obesity, as well as other gastrointestinal disorders. The Company's device-based therapies are an alternative to invasive surgical procedures. The... 
More about the company
Surperformance© ratings of Apollo Endosurgery Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on APOLLO ENDOSURGERY INC
2018APOLLO ENDOSURGERY, INC. : Entry into a Material Definitive Agreement, Completio..
AQ
2018APOLLO ENDOSURGERY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
2018APOLLO ENDOSURGERY, INC. : Results of Operations and Financial Condition, Financ..
AQ
2018APOLLO ENDOSURGERY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
2018APOLLO ENDOSURGERY, INC. : Results of Operations and Financial Condition, Financ..
AQ
2018APOLLO ENDOSURGERY : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
AQ
2018APOLLO ENDOSURGERY, INC. : Reports Second Quarter 2018 Results
BU
2018APOLLO ENDOSURGERY, INC. : to Report Second Quarter Results on August 8, 2018
BU
2018APOLLO ENDOSURGERY : Stefanie L. Cavanaugh Buys 4,545 Shares of Apollo Endosurge..
AQ
2018APOLLO ENDOSURGERY, INC. : Other Events (form 8-K)
AQ
More news
Sector news : Medical Equipment
01/17BECTON DICKINSON AND : Says First-Quarter Profit Will Top Views
DJ
01/16PG&E to get pulled out of S&P 500, shares near 2001 lows
RE
01/16ABBOTT LABORATORIES : Exercises Option to Buy Cephea Valve Technologies
DJ
01/14ABBOTT LABORATORIES : Labs Gets FDA Approval for Amplatzer Piccolo Occluder
DJ
01/10Hearing aid makers Widex and Sivantos reopen EU merger application
RE
More sector news : Medical Equipment
Chart APOLLO ENDOSURGERY INC
Duration : Period :
Apollo Endosurgery Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends APOLLO ENDOSURGERY INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 4
Average target price 5,81 $
Spread / Average Target 72%
EPS Revisions
Managers
NameTitle
Todd Newton Chief Executive Officer & Director
Richard J. Meelia Chairman
Stefanie Cavanaugh Chief Financial Officer & Secretary
Christopher J. Gostout Chief Medical Officer
Matthew S. Crawford Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
APOLLO ENDOSURGERY INC-2.03%74
ABBOTT LABORATORIES-1.26%125 437
MASIMO CORPORATION12.34%6 392
ASAHI INTECC CO., LTD.6.21%5 669
PENUMBRA INC16.20%4 899
JIANGSU YUYUE MDCL EQPMNT & SPPLY CO LTD--.--%3 121